Meeting
2021 Genitourinary Cancers Symposium
Impact of angiotensin inhibitors on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
Presenter
Jonathan Thomas, MD
Beth Israel Deaconess Medical Center, Harvard Medical School
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Therapeutics
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 432)
DOI
10.1200/JCO.2021.39.6_suppl.432
Abstract #
432
Poster Bd #
Online Only
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2022 ASCO Genitourinary Cancers Symposium
Impact of angiotensin-converting enzyme inhibitors (ACEi) on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
Speaker: Jonathan Thomas, MD
Videos & Slides
2024 ASCO Annual Meeting
Association between stromal tumor-infiltrating lymphocytes (TILs) and pathologic complete response (pCR) in patients with early breast cancer (BC) treated with neoadjuvant chemotherapy and HER2-directed therapies in NSABP B-41.
Speaker: Ilana Schlam, MD, MPH
Videos & Slides
2023 ASCO Annual Meeting
Setting Boundaries While Maintaining Trust: The Good, the Bad, and the Ugly
Speaker: Arif Kamal, MD, MBA, FAAHPM, FASCO, MHS
Videos & Slides
2023 ASCO Annual Meeting
The Next Frontier: Resistance to ADCs and Combination Strategies
Speaker: Erika P. Hamilton, MD